Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Cantech ...

<< Previous

Bullboard Posts

Next >>

Comment by EbbFlow88on Sep 10, 2021 8:47am

81 Views

Post# 33838926

RE:RE:RE:Cantech ...

MrMugsy wrote:

Chianchin wrote: They have been pedling the same BS story for eight years and the sare price went from $10 to $5

Keep in mind Chi-Chi ... the word is "peddling."

For example ... used in a sentence ... "Chi-Chi constantly peddles his fear of the share price and it holds him back from seeing the real story."

Also keep in mind that it isn't the share price that matters (unless you're selling) - it's the strategy and the journey in building ROW. What matters is what the company becomes. I know it's a difficult concept, but think back to all the wonderful stories I shared with you over the years about having to wait. This will take time.

Look where we've come in a few short years ...

Note for Chi-Chi ... company started in Nov 2014 ... so ... November 2021 will be 7 years, not 8.

-----

Knight Therapeutics

Year Revenue Net Income
2020 199,519,000 32,085,000
2019 47,461,000 18,033,000
2018 12,500,000 24,079,000
2017 8,634,000 17,244,000
2016 5,940,000 18,560,000
2015 1,037,000 34,167,000
2014 365,000 125,859,000

-----